Abstract 3874: Developing a nanoformulation of the PARP inhibitor talazoparib as a novel delivery for treatment of BRCA-deficient breast cancerDi Zhang,Paige Baldwin, Srinivas Sridhar,Karen T. LibyCancer Research（2018）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
